Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 22 | 2022 | 312 | 7.750 |
Why?
|
| Antipsychotic Agents | 9 | 2022 | 374 | 2.920 |
Why?
|
| Psychotic Disorders | 6 | 2022 | 138 | 2.890 |
Why?
|
| Clozapine | 2 | 2022 | 24 | 1.540 |
Why?
|
| Suicide, Attempted | 6 | 2022 | 132 | 1.500 |
Why?
|
| Marijuana Abuse | 3 | 2019 | 49 | 1.220 |
Why?
|
| Toxoplasmosis | 4 | 2016 | 21 | 1.090 |
Why?
|
| Kynurenine | 2 | 2016 | 21 | 1.020 |
Why?
|
| Schizophrenic Psychology | 6 | 2018 | 82 | 0.980 |
Why?
|
| Gliadin | 2 | 2016 | 5 | 0.950 |
Why?
|
| Bipolar Disorder | 6 | 2019 | 357 | 0.940 |
Why?
|
| S100 Calcium Binding Protein beta Subunit | 2 | 2021 | 16 | 0.780 |
Why?
|
| Veterans | 2 | 2022 | 1748 | 0.690 |
Why?
|
| Interleukin-6 | 1 | 2021 | 420 | 0.640 |
Why?
|
| C-Reactive Protein | 2 | 2019 | 433 | 0.620 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 358 | 0.550 |
Why?
|
| L-Selectin | 1 | 2017 | 22 | 0.550 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 31 | 0.530 |
Why?
|
| Tryptophan | 1 | 2016 | 91 | 0.520 |
Why?
|
| Triglycerides | 1 | 2019 | 575 | 0.510 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 203 | 0.510 |
Why?
|
| Dyslipidemias | 1 | 2019 | 234 | 0.510 |
Why?
|
| Overweight | 1 | 2019 | 364 | 0.500 |
Why?
|
| Immunoglobulin G | 2 | 2016 | 779 | 0.500 |
Why?
|
| Body Mass Index | 2 | 2019 | 1568 | 0.490 |
Why?
|
| Length of Stay | 3 | 2019 | 1313 | 0.490 |
Why?
|
| Toxoplasma | 2 | 2012 | 15 | 0.470 |
Why?
|
| Affective Symptoms | 1 | 2015 | 59 | 0.470 |
Why?
|
| Mood Disorders | 2 | 2018 | 125 | 0.460 |
Why?
|
| Cognitive Dysfunction | 1 | 2018 | 236 | 0.450 |
Why?
|
| Adult | 20 | 2021 | 29734 | 0.450 |
Why?
|
| GTP Cyclohydrolase | 1 | 2014 | 5 | 0.450 |
Why?
|
| Phenylalanine | 1 | 2014 | 128 | 0.430 |
Why?
|
| Hospitals, Psychiatric | 3 | 2018 | 68 | 0.410 |
Why?
|
| Middle Aged | 18 | 2021 | 27000 | 0.410 |
Why?
|
| Male | 26 | 2021 | 61776 | 0.400 |
Why?
|
| Cognition | 2 | 2017 | 729 | 0.390 |
Why?
|
| Female | 26 | 2021 | 66998 | 0.380 |
Why?
|
| Inflammation | 1 | 2019 | 1447 | 0.370 |
Why?
|
| Antibodies, Protozoan | 1 | 2011 | 76 | 0.360 |
Why?
|
| Medication Adherence | 1 | 2015 | 400 | 0.350 |
Why?
|
| Coronavirus | 1 | 2010 | 26 | 0.350 |
Why?
|
| Smoking | 2 | 2013 | 1051 | 0.340 |
Why?
|
| Hypercholesterolemia | 1 | 2013 | 230 | 0.340 |
Why?
|
| Influenza B virus | 1 | 2010 | 87 | 0.340 |
Why?
|
| Humans | 36 | 2022 | 125667 | 0.340 |
Why?
|
| Autoantibodies | 1 | 2013 | 435 | 0.330 |
Why?
|
| Influenza A virus | 1 | 2010 | 139 | 0.320 |
Why?
|
| Cognition Disorders | 2 | 2014 | 551 | 0.320 |
Why?
|
| Case-Control Studies | 4 | 2021 | 3312 | 0.280 |
Why?
|
| Aging | 1 | 2013 | 1182 | 0.250 |
Why?
|
| Young Adult | 7 | 2019 | 9093 | 0.250 |
Why?
|
| Coronavirus Infections | 1 | 2010 | 361 | 0.240 |
Why?
|
| Substance Abuse Detection | 2 | 2015 | 42 | 0.240 |
Why?
|
| Suicidal Ideation | 3 | 2019 | 222 | 0.230 |
Why?
|
| Influenza, Human | 1 | 2010 | 662 | 0.220 |
Why?
|
| Comorbidity | 3 | 2019 | 1537 | 0.220 |
Why?
|
| Hypertension | 1 | 2013 | 1332 | 0.220 |
Why?
|
| Suicide | 2 | 2019 | 179 | 0.210 |
Why?
|
| Self-Injurious Behavior | 2 | 2015 | 64 | 0.210 |
Why?
|
| Cocaine | 2 | 2015 | 207 | 0.210 |
Why?
|
| Linear Models | 2 | 2016 | 687 | 0.200 |
Why?
|
| Odds Ratio | 3 | 2016 | 1261 | 0.200 |
Why?
|
| Violence | 2 | 2013 | 115 | 0.190 |
Why?
|
| Neuropsychological Tests | 2 | 2017 | 922 | 0.180 |
Why?
|
| P-Selectin | 1 | 2021 | 80 | 0.180 |
Why?
|
| Cannabinoids | 2 | 2019 | 31 | 0.180 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 817 | 0.170 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3439 | 0.170 |
Why?
|
| Patient Admission | 2 | 2018 | 185 | 0.160 |
Why?
|
| Biomarkers | 2 | 2021 | 3095 | 0.150 |
Why?
|
| Depressive Disorder, Major | 2 | 2016 | 405 | 0.150 |
Why?
|
| Safety-net Providers | 1 | 2018 | 52 | 0.140 |
Why?
|
| Pilot Projects | 1 | 2021 | 1397 | 0.140 |
Why?
|
| Antipyretics | 1 | 2016 | 8 | 0.140 |
Why?
|
| Psychomotor Agitation | 1 | 2016 | 56 | 0.130 |
Why?
|
| Delirium | 1 | 2017 | 55 | 0.130 |
Why?
|
| Patient Discharge | 2 | 2019 | 496 | 0.130 |
Why?
|
| Obesity | 2 | 2019 | 2252 | 0.130 |
Why?
|
| Nurses | 1 | 2016 | 67 | 0.130 |
Why?
|
| Anti-Anxiety Agents | 1 | 2015 | 74 | 0.120 |
Why?
|
| Aged | 4 | 2021 | 19900 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2015 | 133 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 627 | 0.110 |
Why?
|
| Psychopathology | 1 | 2014 | 32 | 0.110 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2019 | 361 | 0.110 |
Why?
|
| United States | 2 | 2021 | 10942 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 115 | 0.110 |
Why?
|
| Tyrosine | 1 | 2014 | 154 | 0.110 |
Why?
|
| Psychiatry | 1 | 2016 | 263 | 0.110 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2016 | 167 | 0.110 |
Why?
|
| Scotland | 1 | 2013 | 17 | 0.100 |
Why?
|
| Demography | 1 | 2014 | 240 | 0.100 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 590 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2014 | 174 | 0.100 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 259 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 188 | 0.100 |
Why?
|
| Germany | 1 | 2013 | 66 | 0.100 |
Why?
|
| Diastole | 1 | 2013 | 176 | 0.100 |
Why?
|
| Seasonal Affective Disorder | 1 | 2012 | 3 | 0.100 |
Why?
|
| Risk Assessment | 1 | 2021 | 3470 | 0.100 |
Why?
|
| Phototherapy | 1 | 2012 | 35 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2014 | 365 | 0.090 |
Why?
|
| Adolescent | 4 | 2014 | 19441 | 0.090 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 182 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 677 | 0.090 |
Why?
|
| Reading | 1 | 2012 | 79 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 855 | 0.090 |
Why?
|
| Seasons | 1 | 2012 | 312 | 0.080 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 1070 | 0.080 |
Why?
|
| Physicians | 1 | 2016 | 589 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2013 | 871 | 0.080 |
Why?
|
| Cholesterol | 1 | 2013 | 542 | 0.080 |
Why?
|
| Brain | 2 | 2021 | 3008 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 415 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 837 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 1445 | 0.080 |
Why?
|
| Depressive Disorder | 1 | 2010 | 456 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2013 | 1377 | 0.070 |
Why?
|
| Risk Factors | 4 | 2016 | 10340 | 0.070 |
Why?
|
| Internship and Residency | 1 | 2016 | 1186 | 0.060 |
Why?
|
| Age Factors | 1 | 2013 | 2831 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2019 | 16417 | 0.060 |
Why?
|
| Logistic Models | 1 | 2010 | 1816 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 2918 | 0.060 |
Why?
|
| Statistics as Topic | 2 | 2014 | 257 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2013 | 6171 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 2014 | 1021 | 0.040 |
Why?
|
| Animals | 1 | 2021 | 34349 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2021 | 256 | 0.040 |
Why?
|
| Psychiatric Nursing | 1 | 2016 | 6 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 309 | 0.030 |
Why?
|
| Benzodiazepines | 1 | 2015 | 103 | 0.030 |
Why?
|
| Inpatients | 1 | 2019 | 500 | 0.030 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 52 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2014 | 60 | 0.030 |
Why?
|
| Catalase | 1 | 2014 | 71 | 0.030 |
Why?
|
| Syndrome | 1 | 2017 | 1121 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 184 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2016 | 472 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 823 | 0.020 |
Why?
|
| Eye Movements | 1 | 2012 | 71 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1901 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1122 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 436 | 0.020 |
Why?
|
| Hospitalization | 1 | 2018 | 1790 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2012 | 274 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2467 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4843 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 1201 | 0.020 |
Why?
|
| Mass Screening | 1 | 2012 | 787 | 0.020 |
Why?
|
| Mental Disorders | 1 | 2012 | 829 | 0.010 |
Why?
|
| Pregnancy | 1 | 2016 | 7223 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2012 | 3745 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2012 | 12420 | 0.010 |
Why?
|